Skip to main content
. 2014 Mar 17;9(3):e91644. doi: 10.1371/journal.pone.0091644

Figure 2. Immunoreactivity of invasive, high-grade dysplasia, low-grade dysplasia and normal tissues of the uterine cervix.

Figure 2

(A) High RRM2 immunostaining (left) and low RRM2 immunostaining (right) in cervical cancer tissues. (B) High RRM2 immunostaining (left) and low RRM2 immunostaining (right) in cervical high-grade dysplasia. (C) High RRM2 immunostaining (left) and low RRM2 immunostaining (right) in cervical low-grade dysplasia. (D) High RRM2 immunostaining (left) and low RRM2 immunostaining (right) in normal cervical tissues. Magnification: 200×; RRM2, ribonucleotide reductase M2.